Jump to content
IGNORED

Vakcinacija


Tsai

Vakcinacija  

328 members have voted

  1. 1. Da li ćete se vakcinisati?

    • Da, prvom prilikom
      220
    • Da, ali ne odmah, sačekao bih prvi talas reakcija
      58
    • Ne zasad, ali sam spreman da promenim mišljenje
      16
    • Ne, nikako
      20
    • Ne znam
      14
  2. 2. Koju vakcinu biste napre uzeli?

    • Pfizer and BioNTech
      144
    • Moderna
      14
    • Sputnik V
      25
    • AstraZeneca
      21
    • Sinopharm China
      10
    • Svejedno mi je
      114


Recommended Posts

Jeste, ali ovo važi za vakcinisane.
Ok, važi i za mnoge druge, prvenstveno mlade i zdrave, ali ipak, mnogi antivakseri će nastradati.
Davno je bilo rečeno, ili ćeš se vakcinisati ili ćeš se razboljeti. Trećeg izgleda da nema.
ono shto je fantazija jeste da se uopshte ne zna ko je spram korone mlad i zdrav. pa kako ko voli.



sent from novi mnogo jak bubamoto.

Link to comment
4 hours ago, Nikodije said:

drkon najavljuje potrebu razdvajanja vakcinisanih i nevakcinisanih. izgleda da on ne veruje u delotvornost vakcine. ja, recimo, verujem, i uopste ne vidim potrebu da me bilo ko razdvaja od bilo koga jer racunam da sam zasticen i da necu umreti ako dodjem u kontakt sa virusom.

Verovatno nećeš. Ali vakcina mu dodje kao kišobran - ako pada, ostaćeš suv, ali ako  pljušti i duva košava, najebaćeš. 

  • +1 2
Link to comment

 

Quote

Is Israel or the UK right when it comes to COVID-19 vaccine effectiveness? According to one Israeli researcher, both sets of data could be correct. Here is why:

By MAAYAN JAFFE-HOFFMAN   
JULY 24, 2021 18:21
 
Is the Pfizer coronavirus vaccine 88% or only 39% effective against preventing symptomatic infection?
 
Two separate studies, one published by the Israeli Health Ministry and the other published in the New England Journal of Medicine late Thursday showed striking differences.
 
“This discrepancy is kind of unsettling and needs to be further investigated,” said Prof. Cyrille Cohen, a member of the advisory committee for clinical trials on SARS-COV2 vaccines at the Health Ministry.
 
Specifically, the ministry's study found that the Pfizer coronavirus vaccine was only 40% effective against symptomatic cases of COVID-19 and 39% effective at stopping infection at all against the Delta variant.
 
 
 
It did, however, show that the vaccine remains 91% effective against developing serious cases of the disease and 88% effective against hospitalization. 
 
The British study, in contrast, found that two doses of the Pfizer vaccine was 88% effective against stopping symptomatic infection against the Delta variant. 
 
The Delta variant is currently responsible for more than 90% of cases in the country and has been found to be significantly more contagious.
 
According to Cohen, there are several possible answers to the data gap.
 
 
FIRST and critical is the difference in time between exposure to the Delta variant and vaccination. 
 
England vaccinated at a much slower pace than Israel, meaning that the majority of its population was only fully vaccinated by mid-April 2021. This is in contrast to Israel, where around 90% of the country’s most vulnerable population were jabbed by the end of January. 
 
It is beginning to become clear that vaccine immunity begins to wane after about six months. The Israeli study showed that for people vaccinated more than six months ago, the effectiveness of the vaccine at stopping coronavirus dropped to as low as 16%.
 
Among more than 1.8 million people who received two shots by January 31, some 5,770 contracted the virus – and 1,181 of them, or 20% of all new infections, were contracted during the week of July 11 to 17, the Health Ministry reported.
 
“If you take into account that they [the UK population] vaccinated later and were exposed to the Delta variant a month before us,” Cohen said, “it could make sense that at the point they checked, they had around 80% effectiveness. The question is what is going to happen in three months? Will they see the same efficacy that we are seeing?”
 

THE NEXT issue is age. 
 
Both Israel and the UK were careful to first vaccinate healthcare workers and the elderly. In England, however, the older population was largely administered the AstraZeneca vaccine, whereas people under 40 were offered Pfizer or Moderna as an alternative due to evidence linking AstraZeneca to rare blood clots. The same study showed that the AstraZeneca vaccine was only 67% effective against symptomatic disease after two doses. 
 
In Israel, everyone received Pfizer. Breakthrough infections were most prominent among people 60 and older, a cohort that already has a greater tendency to be immunocompromised and prone to developing symptomatic if not severe cases of COVID-19.
 
A third explanation relates to the level of PCR testing carried out in the two countries. Israel uses a more sensitive or stringent PCR testing regime than the UK.
 
Genetic matter from the virus is amplified in cycles by PCR tests. The more cycles that are run, the more likely the lab is to detect the virus. Israel uses 37 amplifying cycles, which means that you are positive for the coronavirus even if the test process required up to 37 cycles to detect the virus.
 
“If the PCR testing is less sensitive, England may miss some cases – or Israel may catch more cases – and that could play a role in the numbers,” Cohen said. 
 

FINALLY, a separate Oxford University study that was published over the weekend found that an eight-week gap between the first and second doses of the Pfizer vaccine is a “sweet spot” when it comes to generating neutralizing antibodies. 
 
When England launched its vaccination campaign, it did not have enough doses to vaccinate the population according to Pfizer’s recommended regime of two doses three weeks apart. As such, it spread doses out to between four and 12 weeks to allow more people to get at least one jab. 
 
Specifically, the new research showed that neutralizing antibody levels, the level of those antibodies responsible for defending cells from pathogens, were higher after the extended dosing interval (six to 14 weeks) compared to the conventional three-to-four-week regime.
 
In contrast, the T cell response was of a marginally lower magnitude after the longer dosing interval. T cells provide longer-term immunity and scientists believe that they could provide some immunity to COVID-19, even when antibodies become less effective at fighting the disease.
 
“The question is would you wait eight weeks when there is a pandemic?” Cohen asked, noting that separate studies have shown that one dose of the Pfizer vaccine is only around 30% effective against the Delta variant, which would leave the population vulnerable for two months. “It’s a tough question.”
 
Cohen's solution is to provide a third shot to the most vulnerable people, which new research is starting to show does a good job in boosting antibody levels.
 
“We are still learning the best way to immunize people with these vaccines,” he said. “But we are still in the middle of the pandemic.”

 

Edited by vememah
  • +1 1
Link to comment
23 hours ago, Friend said:

Upravo ono sto smo spominjali da ce se korona svesti na sezonsku infekciju nesto slicno gripu - mozes da se zarazis, smlacen si par dana i to je sve.

Nije samo to, važan je i Long Covid.

Link to comment
Konjara bi da odvaja vakcinisane od nevakcinisanih...ili sam ja to nešto pobrljavio?
konjara, poshto nas je zabrunuto pustio da se bavimo sami sobom, evo ima i jache od godinu dana, mogao bi i sada da nas pusti, ionako sve vec reshavamo sami, kao i do sada. mislim tachno na vakcinisane, dobro smo se pokazali, umemo. ovi drugi jebiga, i oni imaju to shto rade pa neka rade, imaju svoje izbore pa kako hoce. ako pak ispadne da je zajebano, ima valjda te bolnice. jedino shto ce tamo da leche mashinski inzenjeri, oni umeju u protoke i cevi, al shta da se radi. ja bih da mi lepo nastavimo gde smo stali, pa ko ziv ko muerte (shto kazu avaksi od nechega mora da se umre dry.png ). ima i onlajn, za srecnike koji mogu lakshe da se izvuku iz realnosti, al uvek je tako bilo u istoriji. ja vishe zivce za ovo nemam dry.png

a i on, ko neki pop da izadje i jadikuje nad mini suknjama ili tako neshto, idi bre chicha gledaj si posla. sve ti proshlo [emoji38]ol:

ja sam izgleda cao sa tom prichom :unsure:

sent from novi mnogo jak bubamoto.




  • +1 3
Link to comment

mislim, prashtajte, malo sam besna. nije uredu da se namerno zarazava narod, naravno da nije. samo neka se ostavi prostor da ko nece ne mora. ali ni to ne moze dry.png

sent from novi mnogo jak bubamoto.



  • +1 1
  • -1 1
Link to comment
7 minutes ago, gospa buba said:

mislim, prashtajte, malo sam besna. nije uredu da se namerno zarazava narod, naravno da nije. samo neka se ostavi prostor da ko nece ne mora. ali ni to ne moze dry.png

sent from novi mnogo jak bubamoto.


 

Problem je u tome sto se naviklo da se misli iz jedne glave, a ta glava je sad u mašini za mlevenje, pa ostale glave ne znaju šta da misle i sad lupetaju...

 

Kako ovo o mlevenju™ bude eskaliralo, u sve više oblasti će biti glupetanja™, sve više i više...Iako deluje nemoguće...

 

Treba pratiti šta radi Mali ovih dana, hoće uopšte da se vrati sa brčkanja™...

  • +1 3
Link to comment
...
 
Treba pratiti šta radi Mali ovih dana, hoće uopšte da se vrati sa brčkanja[emoji769]...
pa jel beshe u brbana ushla ovih dana u neki avion u neocekivanom nekom dzempericu, sa gospodjom? unsure.gif

sent from novi mnogo jak bubamoto.



Link to comment

Tako je bubivičijuse! Jedino je tu frka zbog nevakcinisanih koji žele, ali ne smeju.

 

Ne mislim na ovo pitanje, ne znam odgovor.

Edited by Milošica
Link to comment
Quote

"Svi građani imaju prava da prime treću dozu" 
Kada je reč o trećoj dozi vakcine, Stručni komitet je dao preporuku za nju.

"Svi se spremamo da mirno dočekamo jesen i razmišljamo o čuvanju zdravlja i mislim da jedan veliki deo građana postupa onako kako treba, a treća doza je nešto što nam treba posebno za određene kategorija stanovništva", rekao je Đerlek.

Ističe da su to hronični bolesnici, pacijenti sa malignim bolestima, transplantirani pacijenti, posebno oni sa transplantacijom koštane srži, pacijenti stariji od 70 godina, pacijenti stariji od 60 godina u domovima za stare, zaposleni u zdravstvu i službama socijalne zaštite.

"Moramo biti jasni da imaju pravo i svi građani gde nije bilo očekivanog imunološkog odgovora da se jave i prime treću dozu", dodao je Đerlek.

Na pitanje da li je preporuka da se uzme ista vakcina ili ne, Đerlek kaže da je preporuka da treća doza bude "Fajzerova" ili "Modernina" vakcina, koja će doći na jesen.

"Ali to ne isključuje da možemo birati bilo koju od četiri vakcine koje je odbrila naša Agencija za lekove", poručio je Đerlek.

Na pitanje zašto "Fajzerova" ili "Modernina", Đerlek kaže su ispitivanja koja su vršena na velikom uzorku u svetu i na osnovu iskustva koja ima Stručni komitet pokazala da daju brži imunološki odgovor.

"Međutim, i sve ostale vakcine su kvalitetne i ne možemo ih zanemariti", naglasio je Đerlek.

 

"Zdravstveni radnici treba da pokažu odgovornost"
Govoreći o obaveznoj vakcinaciji zdravstvenih radnika, Đerlek kaže da oni treba da pokažu primer i odgovornost i da ne mogu lečiti ljude ako postoji mogućnost da ih zaraze.

"S druge strane, ne možemo dozvoliti da ljudi koji dođu i budu negativni na antigenskom testu zaraze zdravstvene radnike", kaže Đerlek.

Naglasio je da podržava obaveznu vakcinaciju zdravstvenih radnika.

"Država neće nameteti globalnu obaveznu vakcinaciju stanovništva, ostavićemo i dalje da ljudi biraju da li će se vakcinisati ili ne i to na savest i odgovornost", zaključio je Đerlek.

https://www.rts.rs/page/stories/sr/Коронавирус/story/3134/koronavirus-u-srbiji/4456875/djerlek-vakcinacija-delta-soj.html

Edited by vememah
Link to comment

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...